Nabriva Therapeutics Stock Quote NBRV - Stock Price, News, Charts, Message Board, Trades

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nabriva Therapeutics PLC (NBRV) Quote

Nabriva Therapeutics PLC (NBRV)

1.42

0.00

(0.00%)

Closed September 25 4:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

1.42

Bid

1.41

Ask

1.47

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

1.42

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

-

Dividend Yield

-

PE Ratio

0.00

Earnings Per Share (EPS)

-

Revenue

37.51M

Net Profit

-57.19M

Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be... Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be the first pleuromutilin antibiotic available for systemic administration in humans. It operates in one reportable segment, which comprises the research and development of novel anti-infective agents to treat serious infections. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.nabriva.com

Headquarters

Dublin, Irl

Founded

-

Form 15-12G - Securities registration termination [Section 12(g)]

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 8-K - Current report

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

Arbutus Appoints Two New Executives

Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus...

Form 8-K - Current report

Nabriva Therapeutics Provides Corporate Update

-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- DUBLIN, Ireland, Jan. 06, 2023 (GLOBE...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RZLVRezolve AI Ltd	$ 7.44 (51.22%)	3.17M
RNAZTransCode Therapeutics Inc	$ 0.63 (51.12%)	12.73M
ATGLAlpha Technology Group Limited	$ 2.16 (49.72%)	3.42M
INVZWInnoviz Technologies Ltd	$ 0.18 (45.69%)	11.02k
OCTOEightco Holdings Inc	$ 3.61 (44.98%)	100.6M
VTNRVertex Energy Inc	$ 0.1501 (-58.42%)	49.72M
CMCTCreative Media and Community Trust Corporation	$ 0.71 (-54.63%)	3.56M
SFIXStitch Fix Inc	$ 2.28 (-39.20%)	23.88M
SHOTWSafety Shot Inc	$ 0.22 (-31.25%)	11.82k
ARQQArqit Quantum Inc	$ 4.40 (-29.63%)	438.63k
NVDANVIDIA Corporation	$ 123.51 (2.18%)	284.49M
MLGOMicroAlgo Inc	$ 0.2744 (26.92%)	142.29M
SQQQProShares UltraPro Short QQQ	$ 7.47 (-2.35%)	124.15M
CEROCERo Therapeutics Holdings Inc	$ 0.0986 (5.23%)	123.59M
INTCIntel Corporation	$ 23.54 (3.20%)	117.01M

tradernewstip

tradernewstip 5 minutes ago

(NASDAQ: $SVRE) est. 13m float, at $0.15/share, oversold RSI 32, strategic partnership with Volvo. Full analysis here >>> https://bestgrowthstocks.com/saverone-2014-ltd-nasdaq-svre-an-in-depth-analysis/

djjazzyjeff

djjazzyjeff 5 minutes ago

No because they already showed their stupid drug isn't any better than what's already available in animals. Maybe they can try to treat bacteria next. Bunch of morons.

canthelpit

canthelpit 6 minutes ago

GTCH porch,,, he posted about THAILAND investing 350 mil for chip factory ....... Thailand Board of Investment (BOI)) has approved a joint venture between PTT, the state-owned energy company, and Hana Electronics to establish a semiconductor factory. The first phase will see an invest

janice shell

janice shell 7 minutes ago

Whatever the truth is, the outcome may be messy. It just isn't possible that the sheriff found out something about the judge in the space of a couple of hours that he believed was reliable enough to warrant shooting him.

linkvest

linkvest 8 minutes ago

NO off the table... Do some DDs and learn before you speak so you don't sound like an ASKhole....

Dj2490

Dj2490 9 minutes ago

Are you here to invest or not???

linkvest

linkvest 9 minutes ago

Don't start that same old BS you did for week before. You know as well as all of us the CEO said they can run to $4 without a RS....You must of sold out today LMAO.... It's going to cost you to get back in tomorrow...

vein

vein 10 minutes ago

Yeah, doesn’t tell us anything we don’t already know

FeMike

FeMike 11 minutes ago

So to be clear, you’re counting on Northwest Bio, whose CEO is petrified of social situations, who has only made two public appearances in the past 4 years, to have an excellent media campaign to support the stock price? When has NWBO ever, EVER, shown that they are capable of handling public relati

crowin

crowin 12 minutes ago

ASII headed to the NYSE!

Nuff said to expose this SCAM!

SilkRoad

SilkRoad 12 minutes ago

Market Cap Comparison:
KBLB: $95.53M
BSLK: $26.98M

Would you like mushrooms on your pizza?

WorstLuck

WorstLuck 13 minutes ago

JNJ

https://endpts.com/jj-folds-cardiovascular-and-metabolic-drug-unit/

Exclusive: J&J folds cardiovascular and metabolic drug unit
Max Bayer
Pharma Reporter
Johnson & Johnson is winding down its pharma division’s cardiovascular and metabolic unit,

StockHobit

StockHobit 13 minutes ago

https://www.otcmarkets.com/stock/CEOS/news/CEOS-Engages-Exclusive-Key-Congressional-Leaders-to-Strengthen-Market-Position-and-Become-the-Category-Leader-in-Billion?id=453737

Stonerex

Stonerex 14 minutes ago

The Company moves forward.We look forward to enormous growth!

tat4tat

tat4tat 14 minutes ago

Potential competition or not? Veterans Benefits Evaluations website popped up on X along with Vetcomm posts, such as another meaningless post about being on the way up and out. Does the shareprice like its on its way up or on its way out.

weedtrader420

weedtrader420 15 minutes ago

$5 soon 🎱YES

JOHNNIEBG

JOHNNIEBG 16 minutes ago

It is just so sad, the 52 week low a week ago was actually higher than what it closed at today. Look how close the price is to the bottom of the scale, yet they want to call it a SURGE !!! It just shows the ignorance of those around it...... I believe that the MAGA supporters are still buying i

SSKILLZ1

SSKILLZ1 16 minutes ago

Well stroman was the guy kicked out of the rotation (Wasn't pitching well) and with nestor hurt who was pitching well the rotation for the playoffs in painfully obvious. Cole, Gil, Schmidt, and Rodon in my opinion.

ChannelTrader

ChannelTrader 18 minutes ago

New York City Mayor Eric Adams indicted after campaign corruption investigation

https://www.foxnews.com/us/new-york-city-mayor-eric-adams-indicted-after-campaign-corruption-investigation

FBI agents raid Bronx home of aide to NYC Mayor Eric Adams

FBI agent

skitahoe

skitahoe 18 minutes ago

I don't believe you're right, but much will depend on how the release is done, and how it is received. Does the release suggest how unique the vaccine is, how it should be considered a new paradigm in the treatment of cancer.

Of course I'm not speaking of the words in the company PR,

meixatech

meixatech 18 minutes ago

$1.35 /share? Wowzers , dare I dream?

Slim_Jim

Slim_Jim 18 minutes ago

Vein - Written by Valkyrie Trading Society

https://seekingalpha.com/article/4723303-lightwave-logic-a-waiting-game-reflexivity-risks-reduced#comments

Lightwave Logic: It's A Waiting Game, Reflexivity Risks Reduced
Sep. 25, 2024 4:22 PM ETLightwave Logic, I

Nabriva Therapeutics

Delayed Upgrade Clock